BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8764636)

  • 1. Magnetic resonance imaging in clinical therapeutic trials of multiple sclerosis.
    Jacobs L
    West J Med; 1996 Jun; 164(6):531-2. PubMed ID: 8764636
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
    Simon JH
    West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.
    Liedtke W; Limmroth V
    Ann Neurol; 1996 Feb; 39(2):276-7. PubMed ID: 8967762
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial measures in multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials.
    Paty DW
    Neurology; 1988 Jul; 38(7 Suppl 2):82-3. PubMed ID: 3386847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of MRI in patients with multiple sclerosis].
    Tourbah A
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1124-7. PubMed ID: 11787344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple sclerosis].
    Scherer C; Dubas F
    Rev Prat; 2009 May; 59(5):695-701. PubMed ID: 19552212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to participate in a multiple sclerosis clinical trial.
    Frank JA; McFarland HF
    Neuroimaging Clin N Am; 2000 Nov; 10(4):817-30 ,x. PubMed ID: 11359727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
    Mathiesen HK; Langkilde AR; Larsson HB
    Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on the therapy of multiple sclerosis (MS).
    Massaro AR
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):137-43. PubMed ID: 1345735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
    Bermel RA; Fisher E; Cohen JA
    Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis].
    Akesson E; Fredrikson S
    Lakartidningen; 2004 Aug; 101(32-33):2489-93. PubMed ID: 15346623
    [No Abstract]   [Full Text] [Related]  

  • 16. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of follow-up and evolution of multiple sclerosis].
    Couvreur G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
    Filippi M; Horsfield MA; Adèr HJ; Barkhof F; Bruzzi P; Evans A; Frank JA; Grossman RI; McFarland HF; Molyneux P; Paty DW; Simon J; Tofts PS; Wolinsky JS; Miller DH
    Ann Neurol; 1998 Apr; 43(4):499-506. PubMed ID: 9546332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.